Press Release | Tissuepathology.com

Aiforia lands EU financing to develop AI-powered cancer detection

Erica Goodpaster — Mon, 03 Aug 2026 11:08:05 +0000

EIB provides €20 million venture debt financing to Finnish life-science company Aiforia, to further develop its AI powered platform used in digital tissue analysis. Supported under the European Commission’s InvestEU programme, the financing will accelerate Aiforia’s product development and boost its commercial operations. Aiforia’s deep learning artificial intelligence (AI) solutions can revolutionise diagnostic capabilities in […]

The post Aiforia lands EU financing to develop AI-powered cancer detection first appeared on Tissuepathology.com.

Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development

Erica Goodpaster — Fri, 31 Jul 2026 11:15:06 +0000

Albuquerque, NM, July 30, 2026 – Indica Labs today announces the launch of the ADC Target Scoring module for the HALO® image analysis platform, a powerful new functionality that supports the development of next-generation precision oncology therapies through quantitative target scoring and spatial analysis. Antibody-drug conjugates (ADC) have emerged as one of the most promising classes of precision oncology […]

The post Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development first appeared on Tissuepathology.com.

Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis

Erica Goodpaster — Wed, 29 Jul 2026 12:34:01 +0000

Albuquerque, NM, July 28, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced new intelligent tissue classification capabilities for HALO Breast IHC AI, its AI-powered breast biomarker quantification suite, seamlessly deployed in HALO AP®. This enhanced new version introduces fully automated identification and exclusion of positive control tissue, ductal carcinoma in situ […]

The post Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis first appeared on Tissuepathology.com.

Ibex Medical Analytics Achieves CE-IVDR Certification for Breast Panel IHCs, Elevating the Standard of Care in AI-Powered Breast Cancer Diagnostics

Erica Goodpaster — Fri, 24 Jul 2026 12:06:23 +0000

Ibex: The clinical validation and regulatory certification of Ibex’s breast IHC workflow is expected to further boost pathology lab performance and enhance patient care BOSTON & TEL AVIV, Israel–(BUSINESS WIRE)–Ibex Medical Analytics (Ibex), the global leader in AI-powered pathology solutions for clinical diagnostics and biopharma, today announced that it has received In Vitro Diagnostic Medical […]

The post Ibex Medical Analytics Achieves CE-IVDR Certification for Breast Panel IHCs, Elevating the Standard of Care in AI-Powered Breast Cancer Diagnostics first appeared on Tissuepathology.com.

Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges

Erica Goodpaster — Thu, 23 Jul 2026 12:03:37 +0000

Roche: Supporting ADLM’s focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics Showcasing Roche’s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901 INDIANAPOLIS, July 22, 2026 /PRNewswire/ — (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing […]

The post Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges first appeared on Tissuepathology.com.

Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform

Erica Goodpaster — Wed, 22 Jul 2026 12:13:49 +0000

OREM, UT, UNITED STATES, July 21, 2026 /EINPresswire.com/ — Techcyte, a worldwide leader in AI-powered digital pathology and diagnostics, today announced it has surpassed 11 million AI-assisted scans processed across active customer environments spanning human, veterinary, and environmental diagnostic platforms. The milestone marks a significant step in the company’s mission to make AI-driven diagnostics accessible to […]

The post Techcyte Marks 11 Million AI-Assisted Scans Across Its Global Platform first appeared on Tissuepathology.com.